Journal article
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine (IPV) in routine immunisation programmes to eliminate vaccine-associated or vaccine-derived poliomyelitis from serotype 2 poliovirus. Because data are needed on sequential IPV–bOPV schedules, the researchers assessed the immunogenicity of two different IPV–bOPV schedules compared with an all-IPV schedule in infants.
Authors
Languages
- English
Publication year
2015
Journal
The Lancet Infectious Diseases
Volume
11
Type
Journal article
Categories
- Service delivery
Diseases
- Polio
Countries
- Chile
Tags
- IPV
- OPV
WHO Regions
- Region of the Americas